Marker Therapeutics Inc (MRKR) — Cash Flow Reinvestment Rate

Latest as of September 2024: 0.00x

Marker Therapeutics Inc (MRKR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $1.00 (capex $1.00 ) from operating cash flow of $1.20 Million. Explore MRKR capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$1.00
Capex + Investments

Operating Cash Flow

$1.20 Million
USD

Capital Expenditures

$1.00
USD

Marker Therapeutics Inc Cash Flow Reinvestment Rate (2001–2001)

Historical reinvestment intensity for Marker Therapeutics Inc across 1 annual periods. Also explore Marker Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Marker Therapeutics Inc (2001–2001)

Year-by-year capital reinvestment analysis for Marker Therapeutics Inc. For live market cap and broader valuation context, see Marker Therapeutics Inc (MRKR) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2001 0.00x $0.00 $2.38K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow